Open AccessThe Association between Thyroid-Stimulating Hormone and Long-Term Outcomes in Patients with ST Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
Author(s) -
Yuansong Zhu,
Jian Shen,
Yuzhou Xue,
Zhenxian Xiang,
Yi Jun,
Wei Zhou,
Suxin Luo
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s333322
Subject(s) - medicine , myocardial infarction , killip class , percutaneous coronary intervention , hazard ratio , cardiology , proportional hazards model , heart failure , hormone , thyroid stimulating hormone , thyroid , clinical endpoint , confidence interval , randomized controlled trial
Thyroid hormones are closely related to the cardiovascular system. Our study aimed to explore the impact of admission thyroid-stimulating hormone (TSH) levels on long-term outcomes in patients with acute ST segment elevation myocardial infarction (STEMI) by detailed stratifications of TSH.